CIK 0001389545 · Non-accelerated filer<br>Smaller reporting company
Stablecoin Development Corp
Sign in to watch- Ticker
- SDEV
- Exchange
- NYSE
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680454536
- Phone
- 561-206-4345
- Business address
- 222 LAKEVIEW AVE, SUITE 800, WEST PALM BEACH, FL, 33401
- Former names
- NovaBay Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-03-03 | Najafi Ramin Chief Executive Officer | Purchase · Warrant | +124,999 | $0.65 | $81K | 291,665 |
| 2015-03-03 | Pioneer Pharma (Singapore) Pte. Ltd. 10% owner | Purchase | +2,590,000 | $0.60 | $1.6M | 9,595,656 |
| 2015-03-03 | Pioneer Pharma (Singapore) Pte. Ltd. 10% owner | Purchase · Warrant | +2,590,000 | $0.60 | $1.6M | 4,532,500 |
| 2015-03-03 | Pioneer Pharma (Singapore) Pte. Ltd. 10% owner | Purchase · Warrant | +1,942,500 | $0.65 | $1.3M | 4,532,500 |
| 2015-01-02 | Radaelli Massimo Director | Grant or award · Stock Option (right to buy) | +15,000 | 45,000 | ||
| 2015-01-02 | Maderis Gail J Director | Grant or award · Stock Option (right to buy) | +121,144 | 277,726 | ||
| 2015-01-02 | Cashion Charles Director | Grant or award · Stock Option (right to buy) | +69,368 | 377,156 | ||
| 2015-01-02 | SIECZKAREK MARK M Director | Grant or award · Stock Option (right to buy) | +92,667 | 156,234 | ||
| 2015-01-02 | McPherson T. Alex Director | Grant or award · Stock Option (right to buy) | +144,444 | 537,279 | ||
| 2015-01-02 | Freiman Paul E. Director | Grant or award · Stock Option (right to buy) | +121,144 | 358,654 | ||
| 2015-01-02 | Wicks Tony D.S. Director | Grant or award · Stock Option (right to buy) | +15,000 | 301,016 | ||
| 2014-12-12 | Stroman David W. SVP, Ophthalmic Product Devt. | Purchase | +10,000 | $0.66 | $7K | 23,000 |
| 2014-12-12 | PAULSON THOMAS J CFO | Purchase | +10,000 | $0.68 | $7K | 68,210 |
| 2014-12-12 | Najafi Ramin Chief Executive Officer | Purchase | +50,000 | $0.65 | $33K | |
| 2014-12-11 | Najafi Ramin Chief Executive Officer | Purchase | +20,000 | $0.60 | $12K | 3,175,000 |
| 2014-12-09 | PAULSON THOMAS J CFO | Purchase | +10,000 | $0.67 | $7K | 58,210 |
| 2014-12-05 | Najafi Ramin Chief Executive Officer | Purchase | +25,000 | $0.65 | $16K | 3,155,000 |
| 2014-12-02 | Najafi Ramin Chief Executive Officer | Purchase | +18,000 | $0.71 | $13K | 3,130,000 |
| 2014-12-02 | Wicks Tony D.S. Director | Sale | −20,000 | $0.70 | $14K | |
| 2014-12-01 | Wicks Tony D.S. Director | Sale | −10,000 | $0.69 | $7K | 213,680 |
Page 15 of 16 · 301 trades